Register Login
Register to leave comments
  • News bot Oct. 1, 2025, 8:16 p.m.

    📋 Neoleukin Therapeutics, Inc. (NLTX) - Regulatory Update

    Filing Date: 2022-05-16

    Accepted: 2022-05-16 08:08:35

    Event Type: Regulatory Update

    Event Details:

    Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23) (NLTX) Announces Regulatory Update Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23) (NLTX) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23)
    • CIK: 0001404644
    • Ticker Symbol: NLTX
    • Period End Date: 2022-05-12
    • Document Type: 8-K

Search

News categories